Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04038567 · ClinicalTrials.gov registry record · NA
Optimizing a Mobile Mindfulness Intervention for ICU Survivors
A NA study of Cardiorespiratory Failure, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 247
- Enrollment target
- 3
- Study locations
NCT04038567 is a NA study of Cardiorespiratory Failure that has completed, run by Duke University. The registered enrollment target is 247 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT04038567, a NA study of Cardiorespiratory Failure, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 247 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a factorial experimental trial involving adult survivors of cardiorespiratory failure treated in intensive care units (ICUs) that is conceptualized as the Optimization Phase of a multiphase optimization strategy (MOST) framework. This will allow optimization of a mobile mindfulness intervention by comparing eight different iterations across domains including impact on symptoms, feasibility, acceptability, usability, scalability, and cost.
Conditions Studied
Interventions
- BEHAVIORAL Mobile mindfulness-based training
Study Locations (3)
Colorado
- University of Colorado - Denver - Aurora
North Carolina
- Duke University Medical Center - Durham
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2019-08-15 |
| Est. Completion | 2023-07-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04038567
The ClinicalTrials.gov registry entry for NCT04038567 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiorespiratory Failure appearing as the primary indexed condition, and to 1 intervention - of which Mobile mindfulness-based training is the first listed.
NCT04038567 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Colorado, North Carolina, Washington.
Frequently Asked Questions
What is clinical trial NCT04038567 about?
NCT04038567 is a clinical study titled "Optimizing a Mobile Mindfulness Intervention for ICU Survivors". This is a factorial experimental trial involving adult survivors of cardiorespiratory failure treated in intensive care units (ICUs) that is conceptualized as the Optimization Phase of a multiphase optimization strategy (MOST) framework. This will allow optimization of a mobile mindfulness intervent...
What is the current status of trial NCT04038567?
This trial is currently completed. It is a NA study. The enrollment target is 247 participants. The study started on 2019-08-15. Estimated completion is 2023-07-19.
What conditions does trial NCT04038567 study?
This clinical trial studies the following conditions: Cardiorespiratory Failure.
What interventions are being tested in trial NCT04038567?
The interventions under investigation include: Mobile mindfulness-based training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04038567?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04038567 being conducted?
This trial has 3 study locations across Colorado, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.